Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-427732
Filing Date
2013-11-05
Accepted
2013-11-05 16:23:16
Documents
13
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d588317d10q.htm 10-Q 489814
2 EX-4.1 d588317dex41.htm EX-4.1 16389
3 EX-10.1 d588317dex101.htm EX-10.1 34057
4 EX-31.1 d588317dex311.htm EX-31.1 9083
5 EX-31.2 d588317dex312.htm EX-31.2 9129
6 EX-32.1 d588317dex321.htm EX-32.1 4729
7 EX-32.2 d588317dex322.htm EX-32.2 4830
  Complete submission text file 0001193125-13-427732.txt   4755487

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ddxs-20130930.xml EX-101.INS 631718
9 XBRL TAXONOMY EXTENSION SCHEMA ddxs-20130930.xsd EX-101.SCH 54879
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ddxs-20130930_cal.xml EX-101.CAL 75860
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ddxs-20130930_def.xml EX-101.DEF 140522
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ddxs-20130930_lab.xml EX-101.LAB 398864
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ddxs-20130930_pre.xml EX-101.PRE 278993
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-246-6400
diaDexus, Inc. (Filer) CIK: 0001036968 (see all company filings)

EIN.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26483 | Film No.: 131192899
SIC: 2834 Pharmaceutical Preparations